June 4, 2009   Sweden
VA.se: Succé för VA portföljen
Diamydaktien är en av VA:s köpfavoriter

Läs hela artikeln här
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research

GAD PRODUCTS